Package 31722-488-30

{"route": ["ORAL"], "spl_id": "48bbe92b-25ab-b099-e063-6294a90a82cb", "openfda": {"upc": ["0331722488303"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["c71f18b7-36a3-4489-96b4-e8fbec4f73a1"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-488-05)", "package_ndc": "31722-488-05", "marketing_start_date": "20251001"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-488-30)", "package_ndc": "31722-488-30", "marketing_start_date": "20251001"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-488-90)", "package_ndc": "31722-488-90", "marketing_start_date": "20251001"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "31722-488_48bbe92b-25ab-b099-e063-6294a90a82cb", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "31722-488", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA217898", "marketing_category": "ANDA", "marketing_start_date": "20251001", "listing_expiration_date": "20271231"}